Knalysis Technologies is part of the Canada House Wellness Group, a publicly-traded Canadian company with one of the largest networks of cannabis clinics in Canada. Knalysis envisioned a need for health technology connecting every aspect of the medical marijuana field, and pioneered software to seamlessly link physician, provider, and patient. Purpose-built in our own clinics, Knalysis’ suite of software has been battle-tested with our 10,000+ patients; treating a broad range of ailments and symptoms.
A lot of organizations are tracking seed to sale in the cannabis space. We’re tracking retail to results.
We are tired of anecdotal information especially where your health is concerned. Why are doctors determining a course of treatment by saying “We heard this strain can help with that…”? Knalysis Technologies goes beyond word of mouth, closing the data loop by quantifying what is truly working for patients treating their symptoms with cannabis. Our suite of fully-customizable, cloud-based software benefits patients, clinics, dispensaries and growers by arming them with the information they need to determine what products and strains to take, prescribe, stock and grow.
Creating Medical Marijuana technologies for better health outcomes.
Our products were developed directly with a national network of clinicians in the medical marijuana domain, and are built to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. A division of Canada House Wellness Group (CSE: CHV)